Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2023 Sep 20;12(1):168–174.e2. doi: 10.1016/j.jaip.2023.09.011

Table 4.

Vancomycin Hepatotoxicity: 9 Cases

Case HLA-A (1) HLA-A (2) Rash Fever Eos Renal DRESS DRESS score Duration Therapy (days) Time to Onset (days) R value Pattern Peak Bilirubin Severity Score Causality Score
1 A*32:01 A*32:01 1 1 1 1 Yes 8 37 20 28.2 HC 3.0 4 3
2 A*25:01 A*32:01 1 1 1 1 Yes 5 22 22 3.7 Mix 0.9 1 2
3 A*02:01 A*03:01 1 1 1 1 Yes 4 15 10 9.9 HC 1.9 3 3
4 A*24:02 A*24:02 0 0 0 0 No 1 1 6* 0.6 Chol 14.3 2 3
5 A*26:01 A*32:01 1 1 Unk 1 Yes 3 26 27 3.4 Mix 19.4 4 3
6 A*01:01 A*32:01 1 1 1 1 Yes 5 31 20 0.8 Chol 0.7 1 2
7 A*03:01 A*32:01 1 1 1 U Yes 5 18 16 0.2 Chol 3.3 3 3
8** A*32:01 A*33:03 1 1 1 1 Yes 6 30 16 2.1 Mix 38.6 5 3
9 A*01:01 A*32:01 1 1 1 1 Yes 6 30 19 1.7 Chol 13.0 4 2
*

History of jaundice after previous exposure to vancomycin.

Initially concomitant medications thought to be an unlikely cause which on re-review was considered at least probable

**

African American, fatal outcome after re-exposure after onset of DRESS and acute exacerbation of liver and renal injury

Abbreviations: HLA, human leukocyte antigen; DRESS, drug-reaction eosinophilia and systemic symptoms; R = (ALT/ULN ÷ Alk P/ULN); ULN, upper limit of normal; HC, hepatocellular; Mix, mixed; Chol, cholestatic; Unk, unknown